Education

• B.S. : Mount Union College, 1972-1976
• M.D. : Ohio State University College of Medicine, 1976-1980
• Internship & Residency : Internal Medicine, Duke University Medical Center, 1980-1983
• Fellow, Laboratory of Clinical Investigation, NIH, 1984-1987
• Fellow, Laboratory of Cellular Metabolism, NIH, 1987-1990

Clinical Interests

• Transplant ID
• Hepatitis C

Research Interests

My research interests focus on clinical and translational research directed at understanding interactions between microbes and the host immune response. My clinical research interests include Clostridium difficile infection, hepatitis C, and emerging infections in transplant recipients. I am also developing collaborative translational research projects, relevant examples include:
 1) utility of noninvasive markers of disease progression and response to therapy in patients with hepatitis C and
 2) examining new molecular assays for early diagnosis of invasive fungal infections in transplant recipients.

Selected References

• Bobak DA, Lemonovich T, Salata RA: Infections in the immunocompromised host, in Cecil'sEssentialsof Medicine. 6th edition, Andreoli TE, Loscalzo J, Carpenter CCJ, and Grigg RC, eds., W.B. Saunders Co., Philadelphia, 2010.
• Bobak DA, Guerrant RL. Nausea, vomiting, and non-inflammatory diarrhea, in Principles and Practiceof Infectious Diseases, 7th edition, Mandell, GL, Bennett JE, and Dolin R, eds. Churchill Livingstone, New York, 2010.
• Bobak D. The next era of HCV antiviral therapy finally begins: part 1. Curr Infect Dis Rep 2010; 12:77-78. PubMed PMID: 21308501
• Bobak D. The next era of HCV antiviral therapy finally begins: part 2. Curr Infect Dis Rep 2010; 12:79-80. PubMed PMID 21308502
• Current Status of Nonatibiotic and Adjunct Therapies for Clostridium difficile Infection. Suwantarat N, Bobak DA Curr Infect . Dis. Rep. 2011 (Feb:13(1):21-7. PubMed PMID: 21308451